Desvenlafaxine Succinate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Desvenlafaxine Succinate
Canada

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Desvenlafaxine Succinate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 27 USDMF, 14 EU WC, 11 KDMF, 15 NDC API, 30 Listed Suppliers, $ API Reference Price

49 API Suppliers
27 USDMF
14 EU WC
11 KDMF
15 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

119 FDF Dossiers, 34 FDA Orange Book, 6 Europe, 20 Canada, 32 Australia, 10 South Africa, 17 Listed Dossiers

119 FDF Dossiers
34 FDA Orange Book
6 Europe
20 Canada
32 Australia
10 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 2 Seqens, 4 DKSH, 1 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 23 Lubricants & Glidants, 20 Thickeners and Stabilizers, 15 Direct Compression, 15 Topical, 13 Film Formers & Plasticizers, 11 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 8 Granulation, 8 Solubilizers, 6 API Stability Enhancers, 5 Chewable & Orodispersible Aids, 5 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Taste Masking, 2 Rheology Modifiers

51 Coating Systems & Additives
29 Fillers, Diluents & Binders
28 Controlled & Modified Release
23 Lubricants & Glidants
20 Thickeners and Stabilizers
15 Direct Compression
15 Topical
13 Film Formers & Plasticizers
11 Co-Processed Excipients
10 Disintegrants & Superdisintegrants
8 Granulation
8 Solubilizers
6 API Stability Enhancers
5 Chewable & Orodispersible Aids
5 Parenteral
5 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
4 Vegetarian Capsules
4 Taste Masking
2 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 6 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
6 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

10 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 Health Canada Patents

3 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 725 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

20 All

01 2ANGITA PHARMA INC.

02 4APOTEX INC

03 2JAMP PHARMA CORPORATION

04 2PFIZER CANADA ULC

05 2PRO DOC LIMITEE

06 2SANDOZ CANADA INCORPORATED

07 2SANIS HEALTH INC

08 2TARO PHARMACEUTICALS INC

09 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

20 All

01 8DESVENLAFAXINE

02 12DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

filter Dosage Form Reset all filters

20 All

01 20TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

20 All

01 2AG-DESVENLAFAXINE

02 2APO-DESVENLAFAXINE

03 2APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

04 4DESVENLAFAXINE

05 2JAMP DESVENLAFAXINE

06 2PRISTIQ

07 2SANDOZ DESVENLAFAXINE

08 2TARO-DESVENLAFAXINE

09 2TEVA-DESVENLAFAXINE

List of Suppliers

Product Main Page

01

APOTEX INC

PharmaVenue

Not Confirmed

APOTEX INC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE

Brand Name : APO-DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 30/100/500

Approval Date :

Application Number : 2466988

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

PharmaVenue

Not Confirmed

APOTEX INC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE

Brand Name : APO-DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging : 30/100/500

Approval Date :

Application Number : 2466996

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

PharmaVenue

Not Confirmed

APOTEX INC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 2467119

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

PharmaVenue

Not Confirmed

APOTEX INC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2467127

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

JAMP PHARMA CORPORATION

PharmaVenue

Not Confirmed

JAMP PHARMA CORPORATION

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : JAMP DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 90

Approval Date :

Application Number : 2495139

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

JAMP PHARMA CORPORATION

PharmaVenue

Not Confirmed

JAMP PHARMA CORPORATION

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : JAMP DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging : 90

Approval Date :

Application Number : 2495147

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : PRISTIQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 30/90

Approval Date :

Application Number : 2321092

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : PRISTIQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging : 30/90

Approval Date :

Application Number : 2321106

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

09

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : TEVA-DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging : 30/100

Approval Date :

Application Number : 2458225

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Brand Name : TEVA-DESVENLAFAXINE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 30/100

Approval Date :

Application Number : 2458217

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?